Paysign(PAYS.US)

Company Encyclopedia
View More
name
Paysign
PAYS.US
Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. It offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card. The company also operates a customer service center; and offers a communication suite, including a kiosk, mobile app, two-way SMS, text alerts, and cardholder web portal.
1.586 T
PAYS.USMarket value -Rank by Market Cap -/-

Financial Score

11/01/2026 Update
C
Transaction and Payment Processing ServicesIndustry
Industry Ranking33/45
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE20.36%A
    • Profit Margin10.10%B
    • Gross Margin56.26%B
  • Growth ScoreB
    • Revenue YoY32.61%A
    • Net Profit YoY-6.24%C
    • Total Assets YoY25.47%A
    • Net Assets YoY60.52%A
  • Cash ScoreB
    • Cash Flow Margin990.22%B
    • OCF YoY32.61%A
  • Operating ScoreC
    • Turnover0.4C
  • Debt ScoreE
    • Gearing Ratio78.16%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Costly Yet Compelling: 3 Elevated P/E Ratio Stocks Poised for Over 60% Gains in 2026

    Three high P/E ratio stocks identified as compelling growth opportunities include PaySign (PAYS), Nebius Group (NBIS), and Riot Platforms (RIOT). PaySign, with a P/E of 37x, has an 84% upside potential, driven by strong revenue growth in patient assistance. Nebius, at 106x P/E, shows a 67% upside, benefiting from AI demand and major contracts with Microsoft and Meta. Riot, with a P/E of 44.9x, has a 77% upside potential, focusing on Bitcoin mining and data-center growth. These stocks are recommended for growth-focused investors.

    Tip Ranks·
    US
    RIOT
    +1.26%
    US
    NBIS
    +0.65%
    US
    PAYS
    +0.41%
    Tip Ranks·
    US
    RIOT
    +1.26%
    US
    NBIS
    +0.65%
    US
    PAYS
    +0.41%

    Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions | PAYS Stock News

    Paysign, Inc. (NASDAQ: PAYS) announced its 2025 performance analysis, highlighting the addition of 55 pharmaceutical copay programs, totaling 131. The company’s Dynamic Business Rules feature saved clients over $325 million by mitigating copay maximizers. In 2025, Paysign supported over 840,000 patients and facilitated more than $950 million in prescription fulfillment expenses. The results reflect significant growth in patient and client savings, showcasing Paysign's commitment to enhancing patient affordability solutions in the healthcare sector.

    StockTitan·
    US
    PAYS
    +0.41%
    StockTitan·
    US
    PAYS
    +0.41%

    Robert Strobo Sells 20,000 Shares of Paysign (NASDAQ:PAYS) Stock

    Robert Strobo, an insider at Paysign, Inc., sold 20,000 shares of the company's stock at $5.47 per share, totaling $109,400. This sale reduced his ownership by 5.76%, leaving him with 327,290 shares valued at $1,790,276.30. The transaction was disclosed in a legal filing with the SEC. Paysign's stock performance showed a slight decrease, trading at $5.49. Analysts have given the stock a "Moderate Buy" rating with a consensus price target of $8.56.

    Market Beat·
    US
    PAYS
    +0.41%
    Market Beat·
    US
    PAYS
    +0.41%

    Paysign Chief Legal Officer Robert Strobo Reports Sale of Common Shares

    Robert Strobo, Chief Legal Officer of Paysign Inc., reported the sale of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system. This news brief was created by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    PAYS
    +0.41%
    Reuters·
    US
    PAYS
    +0.41%

    PaySign’s Strong Financial Performance and Growth Potential Justify Buy Rating

    Maxim Group analyst Michael Diana reiterated a Buy rating on PaySign, setting a price target of $8.50, citing strong financial performance and growth potential. PaySign's Q3 results exceeded expectations, driven by new plasma centers and pharma programs. The company raised its 2025 guidance, has no debt, and positive cash flow. D.A. Davidson also maintained a Buy rating with a $9.00 target. Diana's average return is 0.0% with a 50.80% success rate on stocks.

    Tip Ranks·
    US
    PAYS
    +0.41%
    Tip Ranks·
    US
    PAYS
    +0.41%
    © 2026 Longbridge｜Disclaimer